WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE PROPORTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION AMONG THE PEDIATRIC POPULATION IN THE STATE OF TRIPURA, NORTH EAST INDIA.

Apurba Sarkar, Saikat Majumder, Banti Das, Dr. Gourab Chakraborty and *Dr. Tapan Majumdar

ABSTRACT

Introduction: COVID-19 is a global crisis caused by SARS-COV-2. The virus was first reported in Wuhan, Hubei province, China; in December 2019. The incubation period of the virus is 2 to 14 days, average around 6.5 days in children and 5.4 days in adults. Asymptomatic infections are common in children. Method: ICMR recognized Viral Research & Diagnostic Laboratory of Agartala Government Medical College for conducting RT-PCR test for screening and confirmation of SARS-COV-2. Subsequently, tests were undertaken from 5th March 2020. All the tests were performed as per the testing strategies of ICMR on Strategy for COVID-19 testing in India. Extraction of viral RNA was done as per the manufacturer protocol of QIAGEN for QIAamp Viral RNA Mini Kit. The screening was done by targeting the SARS-CoV-2-specific ‘E gene’. Then the Confirmation was carried out by targeting the ‘RdRp gene’ and ‘ORF-1b’. Result: During this study period out of 100995 samples tested 6571 (7%) were children. 98% (6447) were negative and 2% (124) were positive for SARS-COV-2 by RT-PCR. In positive children, 62% (n=77) was male and 38% (n=47) was female. The most affected age group was 6 to 10 years (33%). The median age was 8 (0-14) years. 81% (n=101) was asymptomatic and 19% (n=23) was symptomatic. Symptoms were similar as Influenza like Symptoms. Conclusion: This study shows that 2% of the tested children were positive for SARS-COV-2, majority of them had positive household contact. 81% were asymptomatic and 19% had moderate symptoms without any mortality. COVID-19 is going to be added as another viral agent of the respiratory panel for future diagnosis and research.

[Full Text Article] [Download Certificate]